Literature DB >> 21747665

Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report.

Giacomo Mugnai1, Mariantonietta Cicoira, Andrea Rossi, Corrado Vassanelli.   

Abstract

Primary systemic amyloidosis is a relatively uncommon disease characterized by the production and deposition of pathological insoluble fibrillar proteins in organs and tissues. It has been estimated that between one-third and one-half of all patients with primary amyloidosis experience clinically significant cardiac involvement. The present study reports a case involving a 77-year-old woman with ischemic heart disease who presented to the cardiology department because of syncope due to slow atrial fibrillation. Laboratory tests revealed a monoclonal spike in the gamma fraction and impairment of renal function, normocytic anemia, mild hypercalcemia, hypoalbuminemia and increased levels of beta-2 microglobulin. Suspicion of cardiac involvement was supported by the echocardiographic pattern and increased levels of troponin I and brain natriuretic peptide, along with clinical signs of heart failure and systemic amyloidosis diagnosis, confirmed by abdominal fat aspiration.

Entities:  

Keywords:  Cardiac amyloidosis; Coronary artery disease; Syncope

Year:  2011        PMID: 21747665      PMCID: PMC3126684     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  17 in total

1.  Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation.

Authors:  W L Miller; R S Wright; C G McGregor; A Dispenzieri; J P McConnell; M F Burritt; A S Jaffe
Journal:  Am J Cardiol       Date:  2001-10-01       Impact factor: 2.778

2.  Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Authors:  Blaithnead Murtagh; Stephen C Hammill; Morie A Gertz; Robert A Kyle; A Jamil Tajik; Martha Grogan
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

Review 3.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

4.  Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure?

Authors:  Melanie Nordlinger; Barbarajean Magnani; Martha Skinner; Rodney H Falk
Journal:  Am J Cardiol       Date:  2005-10-01       Impact factor: 2.778

5.  Validation of an echo-Doppler decision model to predict left ventricular filling pressure in patients with heart failure independently of ejection fraction.

Authors:  Frank Lloyd Dini; Piercarlo Ballo; Luigi Badano; Paolo Barbier; Piersilvio Chella; Umberto Conti; Salvatore Mario De Tommasi; Maurizio Galderisi; Stefano Ghio; Enrico Magagnini; Andrea Pieroni; Andrea Rossi; Cesare Rusconi; Pier Luigi Temporelli
Journal:  Eur J Echocardiogr       Date:  2010-04-17

6.  Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Authors:  Giovanni Palladini; Carlo Campana; Catherine Klersy; Alessandra Balduini; Giovanbattista Vadacca; Vittorio Perfetti; Stefano Perlini; Laura Obici; Edoardo Ascari; Gianvico Melzi d'Eril; Remigio Moratti; Giampaolo Merlini
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

7.  Primary systemic amyloidosis presenting as angina pectoris due to intramyocardial coronary artery involvement: a case report.

Authors:  Shigeru Yamano; Kotomi Motomiya; Yasuhiro Akai; Hideo Shiiki; Takayuki Toyama; Toshio Hashimoto; Shinichi Fujimoto; Shinobu Nakamura; Yoshiaki Fukuoka
Journal:  Heart Vessels       Date:  2002-05       Impact factor: 2.037

8.  Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins.

Authors:  Angela Dispenzieri; Robert A Kyle; Morie A Gertz; Terry M Therneau; Wayne L Miller; Krishnaswamy Chandrasekaran; Joseph P McConnell; Mary F Burritt; Allan S Jaffe
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

Authors:  A G Siqueira-Filho; C L Cunha; A J Tajik; J B Seward; T T Schattenberg; E R Giuliani
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

10.  Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.

Authors:  José-Luis E Velazquez-Ceceña; David L Lubell; Nagapradeep Nagajothi; Hytham Al-Masri; Mumtaz Siddiqui; Sandeep Khosla
Journal:  Tex Heart Inst J       Date:  2009
View more
  2 in total

1.  Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management.

Authors:  Vasvi Singh; Alexander Tiemeier; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

2.  Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review.

Authors:  Kenneth R Kaufman; Arnaldo E Velez; Stephen Wong; Ram Mani
Journal:  Epilepsy Behav Case Rep       Date:  2012-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.